TrialClinical breast cancer2008

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

Helen K Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.